Inventor · disambiguated record
Hans-Ulrich Schmoldt
Also filed as: SCHMOLDT HANS-ULRICH
5 granted patents·6 pending applications·8 citations·filing 2006–2023
72Inventor score
Top patents by PatentIndex Score
11 records- 0179US11046745B2Peptide mimotopes of the CD3 T-cell co-receptor epsilon chain and uses thereofBioNTech SE·Filed 2015·Granted Jun 29, 2021·3 cites·38 claims
- 0275US2023406902A1Peptide mimotopes of claudin 18.2 and uses thereofBioNTech SE·Filed 2023·Application pending·0 cites
- 0370US11673939B2Compositions and methods for diagnosis and treatment of cancerBioNTech SE·Filed 2019·Granted Jun 13, 2023·1 cites·19 claims
- 0468US10858415B2Peptide mimotopes of claudin 18.2 and uses thereofBIONTECH AG·Filed 2014·Granted Dec 8, 2020·1 cites·15 claims
- 0568US8258258B2Dimeric or multimeric microproteinsKOLMAR HARALD·Filed 2006·Granted Sep 4, 2012·2 cites·18 claims
- 0665US2020031898A1Peptide mimotopes of claudin 18.2 and uses thereofBIONTECH AG·Filed 2019·Application pending·0 cites
- 0764US10370433B2Compositions and methods for diagnosis and treatment of cancerBIONTECH AG·Filed 2016·Granted Aug 6, 2019·1 cites·16 claims
- 0856US2025154202A1Cyclic epitope tagsBioNTech SE·Filed 2023·Application pending·0 cites
- 0951US2025339533A1Agents and methods for activation and targeting of immune effector cellsBIONTECH CELL & GENE THERAPIES GMBH·Filed 2022·Application pending·0 cites
- 1050US2024009238A1Agents and methods for targeted delivery to cellsBioNTech SE·Filed 2021·Application pending·0 cites
- 1144US2023049655A1In vitro and in vivo gene delivery to immune effector cells using nanoparticles functionalized with designed ankyrin repeat proteins (darpins)BIONTECH CELL & GENE THERAPIES GMBH·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hans-Ulrich Schmoldt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →